Inhalation is of relevance for all therapeutic indications where systemic exposure is desired. There are multiple advantages with inhalation such as rapid onset of action, lower dosing, avoidance of first pass metabolism and potentially fewer side-effects.
Truly Labs has extensive experience of delivery to the lung and offers a wide range of technological solutions and experimental settings for inhalation studies. We have capabilities to conduct single and repeated dosing, using whole-body or nose-only inhalation exposure. Truly Labs is a member of the Medicon Valley Inhalation Consortium and can facilitate access to a broad range of services related to inhalation from early drug discovery to clinical development.
All of above examples can be performed using single- or repeated dosing.